Enhanced mutation frequency methodology for plant gene analysis
A proven method using chemical mutagens to increase mutation frequency in plants without affecting seed germination. This technique facilitates the isolation of genes for economically important traits, validated through extensive experience and publications.
Overview
This solution offers a robust methodology for increasing mutation frequency in plants through the strategic use of chemical mutagens such as EMS and ENU. The process has been optimized to ensure high mutation rates without compromising seed germination, making it ideal for developing mutant populations for gene analysis. This approach is particularly effective for isolating genes associated with economically important traits such as oil, protein, sugar content, vitamin levels, and disease resistance.
Technical specifications
Key features:
- Utilizes chemical mutagens like EMS and ENU for titration to establish effective mutation rates
- Proven through over 25 years of experience and more than 50 published manuscripts
- Employs TILLING (Targeting Induced Local Lesions IN Genomes) by sequencing and exome capture to identify mutants
- Successfully identifies mutations in highly homologous gene families (up to 98% homology)
Technology readiness level
This method has achieved a Technology Readiness Level of 9, indicating it is fully mature and validated. Future projects can be established with partner organizations to develop and deliver mutagenized seed populations, with flexibility regarding the site of development.
About Southern Illinois University
Southern Illinois University Carbondale is a comprehensive public R1 research university serving the southern Illinois region with broad graduate and professional programs. Industry partners tap a campus research park and business incubator, a coordinated Office of Innovation and Economic Development, and statewide innovation‑network ties that streamline access to talent, facilities, and sponsored research. Through the SIU School of Medicine and its clinical network, companies can engage in translational and clinical collaborations across downstate Illinois. Research is supported by competitive federal and state funding, managed centrally through the Office of Sponsored Projects Administration. A dedicated technology transfer office manages IP, licensing, and industry agreements to accelerate commercialization.
delivered to your inbox.